Potential Molecular Mechanisms of Alzheimer’s Disease from Genetic Studies

Author:

Nwadiugwu Martin1,Shen Hui1,Deng Hong-Wen1ORCID

Affiliation:

1. Tulane Center for Biomedical Informatics and Genomics, Deming Department of Medicine, Tulane University School of Medicine, Tulane University, New Orleans, LA 70112, USA

Abstract

The devastating effects of Alzheimer’s disease (AD) are yet to be ameliorated due to the absence of curative treatment options. AD is an aging-related disease that affects cognition, and molecular imbalance is one of its hallmarks. There is a need to identify common causes of molecular imbalance in AD and their potential mechanisms for continuing research. A narrative synthesis of molecular mechanisms in AD from primary studies that employed single-cell sequencing (scRNA-seq) or spatial genomics was conducted using Embase and PubMed databases. We found that differences in molecular mechanisms in AD could be grouped into four key categories: sex-specific features, early-onset features, aging, and immune system pathways. The reported causes of molecular imbalance were alterations in bile acid (BA) synthesis, PITRM1, TREM2, olfactory mucosa (OM) cells, cholesterol catabolism, NFkB, double-strand break (DSB) neuronal damage, P65KD silencing, tau and APOE expression. What changed from previous findings in contrast to results obtained were explored to find potential factors for AD-modifying investigations.

Funder

National Institutes of Health

Publisher

MDPI AG

Subject

General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology

Reference44 articles.

1. NIA (2023, February 18). Alzheimer’s Fact Sheet, Available online: https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet.

2. World Health Organization (2023, February 18). Dementia. Available online: https://www.who.int/news-room/fact-sheets/detail/dementia.

3. Alzheimer’s Association (2022). 2022 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dement., 18, 700–789.

4. Reduced TREM2 Activation in Microglia of Patients with Alzheimer’s Disease;Okuzono;FEBS Open. Bio,2021

5. Heterogeneity of Alzheimer’s Disease: Consequence for Drug Trials?;Devi;Alzheimers Res. Ther.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3